Table 2.

Gender and outcomes by day-care attendance.

	No Day-care Frequency (%)	Day-care Frequency (%)	p-value*
MAAS
Population	223/727 (30.7)	504/727 (69.3)
Male	112/223 (50.2)	274/504 (54.4)	0.30
Sensitization (SPT)
Age 3 years	47/196 (24.0)	88/450 (19.6)	0.20
Age 5 years	51/200 (25.5)	114/448 (25.5)	0.99
Age 8 years	62/200 (31.0)	130/457 (28.5)	0.51
Age 11 years	52/166 (31.3)	125/397 (31.5)	0.97
Sensitization (IgE)
Age 3 years	13/45 (28.9)	16/84 (19.1)	0.20
Age 5 years	33/134 (24.6)	83/282 (29.4)	0.31
Age 8 years	55/127 (43.3)	112/287 (39.0)	0.41
Atopic wheeze (SPT)
Age 3 years	12/194 (6.2)	26/448 (5.8)	0.85
Age 5 years	15/200 (7.5)	33/447 (7.4)	0.96
Age 8 years	28/200 (14.0)	41/457 (8.9)	0.05
Age 11 years	19/166 (11.5)	38/397 (9.6)	0.50
Atopic wheeze (IgE)
Age 3 years	5/45 (11.1)	7/84 (8.3)	0.61
Age 5 years	10/134 (7.5 )	22/282 (7.8)	0.90
Age 8 years	25/127 (19.7)	28/285 (9.8)	0.01
IIS
Population	133/263 (50.6)	130/263 (49.4)
Male	64/133 (48.1)	56/130 (43.1)	0.46
Sensitization (IgE)
Age 1 year	16/110 (14.5)	10/99 (10.1)	0.40
Age 2 years	26/94 (27.7)	13/93 (14.0)	0.03
Age 3 years	32/88 (36.4)	25/90 (27.8)	0.26
Age 5 years	35/82 (42.7)	27/71 (38.0)	0.62
Atopic wheeze (IgE)
Age 1 year	3/109 (2.8)	3/96 (3.1)	1.00
Age 2 years	7/91 (7.7)	3/90 (3.3)	0.33
Age 3 years	8/86 (9.3)	9/89 (10.1)	1.00
Age 5 years	9/78 (11.5)	7/68 (10.3)	1.00

^*Chi-squared test